| 1. |
Azimi L, Talebi M, Pourshafie MR, Owlia P, Rastegar Lari A. Characterization of carbapenemases in extensively drug resistance Acinetobacter baumannii in a burn care center in Iran. Int J Mol Cell Med 2015;4:46-53.
|
| 2. |
Owlia P, Azimi L, Gholami A, Asghari B, Lari AR. ESBL- and MBL-mediated resistance in Acinetobacter baumannii: A global threat to burn patients. Infez Med 2012;20:182-7.
|
| 3. |
Azimi L, Motevallian A, Ebrahimzadeh Namvar A, Asghari B, Lari AR. Nosocomial infections in burned patients in Motahari hospital, Tehran, Iran. Dermatol Res Pract 2011;2011:436952.
|
| 4. |
Garnacho-Montero J, Ortiz-Leyba C, Fernández-Hinojosa E, Aldabó-Pallás T, Cayuela A, Marquez-Vácaro JA, et al. Acinetobacter baumannii ventilator-associated pneumonia: Epidemiological and clinical findings. Intensive Care Med 2005;31:649-55.
|
| 5. |
Tsakiridou E, Makris D, Daniil Z, Manoulakas E, Chatzipantazi V, Vlachos O, et al. Acinetobacter baumannii infection in prior ICU bed occupants is an independent risk factor for subsequent cases of ventilator-associated pneumonia. Biomed Res Int 2014;2014:193516.
|
| 6. |
Bose S, Khodke M, Basak S, Mallick SK. Detection of biofilm producing staphylococci: Need of the hour. J Clin Diagn Res 2009;3:1915-20.
|
| 7. |
Babapour E, Haddadi A, Mirnejad R, Angaji SA, Amirmozafari N. Biofilm formation in clinical isolates of nosocomial Acinetobacter baumannii and its relationship with multidrug resistance. Asian Pac J Trop Biomed 2016;6:528-33.
|
| 8. |
Liu S, Wang Y, Xu J, Li Y, Guo J, Ke Y, et al. Genome sequence of an OXA23-producing, carbapenem-resistant Acinetobacter baumannii strain of sequence type ST75. J Bacteriol 2012;194:6000-1.
|
| 9. |
Mohammadi F, Goudarzi H, Hashemi A, Yousefi Nojookambari N, Khoshnood S, Sabzehali F. Detection of iSabai in Acinetobacter baumannii strains carrying oxa genes isolated from Iranian burn patients. Arch Pediatr Infect Dis 2017;5:e39307.
|
| 10. |
Royer S, Faria AL, Seki LM, Chagas TP, Campos PA, Batistão DW, et al. Spread of multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa clones in patients with ventilator-associated pneumonia in an adult intensive care unit at a university hospital. Braz J Infect Dis 2015;19:350-7.
|
| 11. |
Krzyściak P, Chmielarczyk A, Pobiega M, Romaniszyn D, Wójkowska-Mach J. Acinetobacter baumannii isolated from hospital-acquired infection: Biofilm production and drug susceptibility. APMIS 2017;125:1017-26.
|
| 12. |
Clinical Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Nineteenth Informational Supplement M100–S21. Wayne, PA: Clinical Laboratory Standards Institute; 2017.
|
| 13. |
Hassan A, Usman J, Kaleem F, Omair M, Khalid A, Iqbal M, Evaluation of different detection methods of biofilm formation in the clinical isolates. Braz J Infect Dis 2011;15:305-11.
|
| 14. |
Higgins PG, Lehmann M, Wisplinghoff H, Seifert H. GyrB multiplex PCR to differentiate between Acinetobacter calcoaceticus and Acinetobacter genomic species 3. J Clin Microbiol 2010;48:4592-4.
|
| 15. |
Nowak P, Paluchowska P, Budak A. Distribution of blaOXA genes among carbapenem-resistant Acinetobacter baumannii nosocomial strains in Poland. New Microbiol 2012;35:317-25.
|
| 16. |
Carr E, Eason H, Feng S, Hoogenraad A, Croome R, Soddell J, et al. RAPD-PCR typing of Acinetobacter isolates from activated sludge systems designed to remove phosphorus microbiologically. J Appl Microbiol 2001;90:309-19.
|